Mar. 17 at 5:18 PM
Shares of Bruker Corporation and 10x Genomics fell after Satya Nadella highlighted GigaTIME, an AI model developed by Microsoft, Providence Health, and the University of Washington that can predict multiplex immunofluorescence results from H&E pathology slides.
The selloff reflected concerns that AI could reduce demand for spatial proteomics, but Wolfe Research argued the reaction was overdone, noting these tools are not yet widely used in clinical settings and the underlying study was published months ago in Cell.
GigaTIME uses multimodal AI trained on 40 million cells and tested across 14,000+ patients, analyzing 21 protein markers including PD-L1. However, Wolfe said this marker set is relatively limited compared to traditional methods, suggesting the technology remains early-stage rather than a near-term replacement.
$BRKR $TXG